Genetic polymorphisms of the renin-angiotensin system in breast cancer patients

Experimental Oncology

Volumn 35, Issue 2, 2013, Pages 101-104

  Fishchuk, L E ^a   Gorovenko, N G ^b  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^b SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

Author keywords

Breast cancer; Gene; Polymorphism; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; UKRAINE;

ADULT; AGED; ANGIOTENSINOGEN; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; UKRAINE; YOUNG ADULT;

EID: 84880910831     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cuneyt K, Buharalioglu CK, Song CY, et al. Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation. Am J Physiol Heart Circ Physiol 2011; 301: H1043-56.
2. Lau ST, Leung PS. Role of the RAS in pancreatic cancer. Curr Cancer Drug Targets 2011; 11: 412-20.
3. Alves Corrêa SA, Ribeiro de Noronha SM, Nogueirade- Souza NC, et al. Association between the angiotensinconverting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women. J Renin Angiotensin Aldosterone Syst 2009; 10: 51-8.
4. González-Zuloeta Ladd AM, Arias-Vasquez A, Siemes C, et al. Differential roles of angiotensinogen and angiotensin receptor type 1 polymorphisms in breast cancer risk. Breast Cancer Res Treat 2007; 101: 299-304.
5. Naglaa RA, Hanan HS, Manal BA, et al. Study of the link of angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism with incidence and pathological criteria of breast cancer. J Am science 2011; 7: 893-900.
6. Shevchenko OV, Svistunov AA, Borodulin VB. Genetic basis of the pathogenesis of essential hypertension (review). Saratov J Med Sci Res 2011; 1: 83-7 (In Russian).
7. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-80.
8. Hoeper MM, Tacacs A, Stellmacher U, et al. Lack of association between angiotensin converting enzyme (ACE) genotype, serum ACE activity, and haemodynamics in patients with primary pulmonary hypertension. Heart 2003; 89: 445-6.
9. Mohammadi F, Shahabi P, Zabani S, et al. Insertion/deletion gene polymorphism and serum level of angiotensin converting enzyme. Tanaffos 2008; 7: 18-22.
10. Obukhova VV, Belushkyna NN. Relationship of angiotensin converting enzyme gene polymorphism with diseases of the cardiovascular system. Problems Biol Med and Pharm Chem 2007; 2: 4-10 (In Russian).
11. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1334-6.
12. Su S, Chen J, Zhao J, et al. Angiotensin II type I receptor gene and myocardial infarction: tagging SNPs and haplotype based association study. The Beijing atherosclerosis study. Pharmacogenetics 2004; 14: 673-81.
13. Cameron VA, Mocatta TJ, Pilbrow AP, et al. Angiotensin II type 1 receptor A116C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 2000; 35: 717-21.
14. Spiering W, Kroon A, Fuss-Lejeune M, et al. Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A1166C polymorphism in essential hypertensives on a high sodium diet. Hypertension 2000; 36: 411-6.
15. Kryvchun AM, Grytsay NM, Kaydashev IP, et al. Peculiarities of hypertensive encephalopathy dyscirculatory depending on the gene polymorphism of angiotensin II receptor type-1. Int Neurol J 2008; 4: 10-5 (In Ukrainian).
16. Lechin M, Quicones MA, Omran A, et al. Angiotensin- I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995; 92: 1808-12.
17. Niu T, Yang J, Wang B, et al. Angiotensinogen gene polymorphisms M235T/T174M: no excess transmission to hypertensive Chinese. Hypertension 1999; 33: 698-702.
18. Russ AP, Maerz W, Ruzicka V, et al. Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993; 2: 609-10.
19. Xie X, Ott J. Testing linkage disequilibrium between a diseasegene and marker loci. Am J Hum Genet 1993; 53: 1107.
20. Namazi S, Monabati A, Ardeshir-Rouhani-Fard S, et al. Association of angiotensin I converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms with breast cancer prognostic factors in Iranian population. Mol Carcinog 2010; 12: 1022-30.
21. Mendizábal-Ruiz AP, Morales J, Castro Martinez X, et al. RAS polymorphisms in cancerous and benign breast tissue. J Renin Angiotensin Aldosterone Syst 2011; 12: 85-92.
22. Koh WP, Yuan JM, Sun CL, et al. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 2003; 63: 573-8.